Novel biomarkers derived from the Maintenance of Wakefulness Test as predictors of sleepiness and response to treatment.

The Maintenance of Wakefulness Test (MWT) is a widely accepted objective test used to evaluate daytime somnolence and is commonly used in clinical studies evaluating novel therapeutics for excessive daytime sleepiness. In the latter, sleep onset latency (SOL) is typically the sole MWT endpoint. Here, we explored microsleeps, sleep probability measures derived from automated sleep scoring, and quantitative electroencephalography (qEEG) features as additional MWT biomarkers of daytime sleepiness, using data from a phase 1B trial of the selective orexin receptor 2 agonist danavorexton (TAK-925) in people with narcolepsy type 1 (NT1) or type 2 (NT2).

Polysomnographic validation of a wireless dry headband technology for sleep monitoring in healthy young adults.

The present study aimed to explore the validity and reliability of a wireless dry headband technology for sleep monitoring (WS), through a comparison with concurrent polysomnographic (PSG) recording in healthy young adults. Eleven volunteers (7 females; mean age±SD: 24.75±3.

Validation of an automated wireless system to monitor sleep in healthy adults.

The availability of a reliable system to record sleep stage measures easily and automatically in ambulatory settings could be of utility for research and clinical work. The aim of this study was to evaluate a novel wireless system (WS) that does not require skilled preparation for the automatic collection and scoring of human sleep. Twenty-nine healthy adults underwent concurrent sleep measurement via the WS, polysomnography (PSG) and an actigraph (ACT) in a sleep laboratory for one assessment night preceded by an acclimation night.